[DreaMed in Business Wire] DreaMed Receives FDA Clearance for its Type 2 Diabetes AI-based Clinical Decision Support System

Following its previous FDA clearance for Type 1 diabetes solution, DreaMed achieves unprecedented validation of its digital endocrinologist expert-care platform.

Read more here.